Ugur Sahin
CIK: 0002123975
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
BioNTech SE
Discretionary Trading P&L
Holdings
Transaction History (26 total)
- Oct 9, 2026BNTX
BioNTech SE
Sale(S)Direct36.2K shares at avg. $95.37$3.5M - Oct 8, 2026BNTX
BioNTech SE
Sale(S)Direct27K shares at avg. $92.31$2.5M - Oct 7, 2026BNTX
BioNTech SE
Sale(S)Direct24K shares at avg. $95.86$2.3M - Oct 6, 2026BNTX
BioNTech SE
Sale(S)Direct21K shares at avg. $96.81$2.0M - Oct 5, 2026BNTX
BioNTech SE
Sale(S)Direct72K shares at avg. $97.23$7.0M - Oct 2, 2026BNTX
BioNTech SE
Sale(S)Direct17K shares at avg. $96.72$1.6M - Oct 1, 2026BNTX
BioNTech SE
Sale(S)Direct17K shares at avg. $97.46$1.7M - Sep 30, 2026BNTX
BioNTech SE
Sale(S)Direct32K shares at avg. $98.12$3.1M - Sep 29, 2026BNTX
BioNTech SE
Sale(S)Direct34K shares at avg. $98.26$3.3M - Sep 28, 2026BNTX
BioNTech SE
Sale(S)Direct34K shares at avg. $98.47$3.3M - Sep 25, 2026BNTX
BioNTech SE
Sale(S)Direct27K shares at avg. $98.69$2.7M - Sep 24, 2026BNTX
BioNTech SE
Sale(S)Direct39K shares at avg. $98.99$3.9M - Sep 23, 2026BNTX
BioNTech SE
Sale(S)Direct30K shares at avg. $99.40$3.0M - Sep 22, 2026BNTX
BioNTech SE
Sale(S)Direct46K shares at avg. $100.72$4.6M - Sep 21, 2026BNTX
BioNTech SE
Sale(S)Direct33K shares at avg. $97.81$3.2M - Sep 18, 2026BNTX
BioNTech SE
Sale(S)Direct30K shares at avg. $96.22$2.9M - Sep 17, 2026BNTX
BioNTech SE
Sale(S)Direct34K shares at avg. $98.60$3.4M - Sep 16, 2026BNTX
BioNTech SE
Sale(S)Direct15K shares at avg. $96.09$1.4M - Sep 15, 2026BNTX
BioNTech SE
Sale(S)Direct34K shares at avg. $96.49$3.3M - Sep 14, 2026BNTX
BioNTech SE
Sale(S)Direct41K shares at avg. $99.45$4.1M - Sep 11, 2026BNTX
BioNTech SE
Sale(S)Direct45K shares at avg. $96.93$4.4M - Sep 10, 2026BNTX
BioNTech SE
Sale(S)Direct20.5K shares at avg. $96.31$2.0M - Sep 9, 2026BNTX
BioNTech SE
Sale(S)Direct36K shares at avg. $97.78$3.5M - Sep 8, 2026BNTX
BioNTech SE
Sale(S)Direct37K shares at avg. $99.20$3.7M - Sep 4, 2026BNTX
BioNTech SE
Sale(S)Direct31.5K shares at avg. $103.52$3.3M
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 9, 2026 | BNTX BioNTech SE | Sale(S) | 36,209 | $95.37 | $3,453,372 | Direct |
| Oct 8, 2026 | BNTX BioNTech SE | Sale(S) | 27,000 | $92.31 | $2,492,483 | Direct |
| Oct 7, 2026 | BNTX BioNTech SE | Sale(S) | 24,000 | $95.86 | $2,300,633 | Direct |
| Oct 6, 2026 | BNTX BioNTech SE | Sale(S) | 21,000 | $96.81 | $2,032,995 | Direct |
| Oct 5, 2026 | BNTX BioNTech SE | Sale(S) | 72,000 | $97.23 | $7,000,646 | Direct |
| Oct 2, 2026 | BNTX BioNTech SE | Sale(S) | 17,000 | $96.72 | $1,644,323 | Direct |
| Oct 1, 2026 | BNTX BioNTech SE | Sale(S) | 17,000 | $97.46 | $1,656,745 | Direct |
| Sep 30, 2026 | BNTX BioNTech SE | Sale(S) | 32,000 | $98.12 | $3,139,850 | Direct |
| Sep 29, 2026 | BNTX BioNTech SE | Sale(S) | 34,000 | $98.26 | $3,340,809 | Direct |
| Sep 28, 2026 | BNTX BioNTech SE | Sale(S) | 34,000 | $98.47 | $3,347,919 | Direct |
| Sep 25, 2026 | BNTX BioNTech SE | Sale(S) | 27,000 | $98.69 | $2,664,581 | Direct |
| Sep 24, 2026 | BNTX BioNTech SE | Sale(S) | 39,000 | $98.99 | $3,860,661 | Direct |
| Sep 23, 2026 | BNTX BioNTech SE | Sale(S) | 30,000 | $99.40 | $2,982,081 | Direct |
| Sep 22, 2026 | BNTX BioNTech SE | Sale(S) | 46,000 | $100.72 | $4,633,037 | Direct |
| Sep 21, 2026 | BNTX BioNTech SE | Sale(S) | 33,000 | $97.81 | $3,227,720 | Direct |
| Sep 18, 2026 | BNTX BioNTech SE | Sale(S) | 30,000 | $96.22 | $2,886,729 | Direct |
| Sep 17, 2026 | BNTX BioNTech SE | Sale(S) | 34,000 | $98.60 | $3,352,342 | Direct |
| Sep 16, 2026 | BNTX BioNTech SE | Sale(S) | 15,000 | $96.09 | $1,441,340 | Direct |
| Sep 15, 2026 | BNTX BioNTech SE | Sale(S) | 34,000 | $96.49 | $3,280,636 | Direct |
| Sep 14, 2026 | BNTX BioNTech SE | Sale(S) | 41,000 | $99.45 | $4,077,315 | Direct |
| Sep 11, 2026 | BNTX BioNTech SE | Sale(S) | 45,000 | $96.93 | $4,362,021 | Direct |
| Sep 10, 2026 | BNTX BioNTech SE | Sale(S) | 20,500 | $96.31 | $1,974,287 | Direct |
| Sep 9, 2026 | BNTX BioNTech SE | Sale(S) | 36,000 | $97.78 | $3,520,145 | Direct |
| Sep 8, 2026 | BNTX BioNTech SE | Sale(S) | 37,000 | $99.20 | $3,670,518 | Direct |
| Sep 4, 2026 | BNTX BioNTech SE | Sale(S) | 31,500 | $103.52 | $3,260,823 | Direct |
1-25 of 26 transactions
About Sahin Ugur
Sahin Ugur (SEC CIK 0002123975) files insider reports with the SEC as Chief Executive Officer of BioNTech SE (BNTX).
Signal8 holds 16 ownership filings by Sahin Ugur (2 Form 3, 14 Form 4), filed between Mar 25, 2026 and Oct 9, 2026. Those filings report 26 transactions, from Sep 3, 2026 to Oct 9, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Sahin Ugur's filings is in MAINZ.
Recent filings by Sahin Ugur
- Oct 9, 2026: Open-market sale of BNTX shares (Form 4, code S).
- Oct 8, 2026: Open-market sale of BNTX shares (Form 4, code S).
- Oct 7, 2026: Open-market sale of BNTX shares (Form 4, code S).
- Oct 6, 2026: Open-market sale of BNTX shares (Form 4, code S).
- Oct 5, 2026: Open-market sale of BNTX shares (Form 4, code S).
Other insiders filing for BioNTech SE (BNTX)
- Low-Friedrich Iris Katharina, Director
- Schaffert Susanne, Director
- Zapata Gomez Ramon, Chief Financial Officer
- Ryan James Timothy Patrick
- Poetting Sierk, Chief Operating Officer
- Jimenez Kylie, Chief People Officer